jueves, 3 de octubre de 2024

Learning and Education to Advance and Empower Rare Disease Drug Developers (LEADER 3D)

https://www.fda.gov/about-fda/accelerating-rare-disease-cures-arc-program/learning-and-education-advance-and-empower-rare-disease-drug-developers-leader-3d?utm_medium=email&utm_source=govdelivery

No hay comentarios: